(Q42825776)

8 November 2017

Apoptosis-inducing membrane vesicles. A novel agent with unique properties (English)

1 reference

8 November 2017

Jodo S

1

1 reference

8 November 2017

Xiao S

2

1 reference

8 November 2017

Hohlbaum A

3

1 reference

8 November 2017

Strehlow D

4

1 reference

8 November 2017

Marshak-Rothstein A

5

1 reference

8 November 2017

Ju ST

6

1 reference

8 November 2017

language of work or name

English

0 references

publication date

23 August 2001

1 reference

Journal of Biological Chemistry

8 November 2017

1 reference

8 November 2017

276

1 reference

8 November 2017

43

1 reference

8 November 2017

39938-39944

1 reference

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

8 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Lethal effect of the anti-Fas antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Fas ligand mediates activation-induced cell death in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Metalloproteinase-mediated release of human Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Downregulation of Fas ligand by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

CD95 (Fas) ligand-expressing vesicles display antibody-mediated, FcR-dependent enhancement of cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Retroviral membrane display of apoptotic effector molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Bioactivities of Fas ligand-expressing retroviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Use of retroviral vectors for gene transfer and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Essential lymphocyte function associated 1 (LFA-1): intercellular adhesion molecule interactions for T cell-mediated B cell apoptosis by Fas/APO-1/CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

B lymphocytes secrete antigen-presenting vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Activated B cells express functional Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107005200

21 January 2018

Identifiers

DOI

10.1074/JBC.M107005200

1 reference

8 November 2017

1 reference